Rebamipide - an overview

Rebamipide Completed Phase 3 Trials for Gastric Ulcer Treatment rebamipide

Customer Review · Description Rebamipide is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially

rebamipide Rebamipide is an amino acid analog of 2 -quinolinone It is being introduced and used since 1980 for the treatment of peptic ulcer  Also known rebamipide has effect, the effect that increases mucus in eyes that increases the intraocular goblet cell density and the effect that increases the Abstract Rebamipide is a cytoprotector developed in Japan where it has been successfully used for the treatment of stomach diseases for 30 years Initially

ททีเด็ดบอล Rebamipide ngăn chặn sự tổn thương niêm mạc dạ dày trong các mô loét, tái cung cấp máu cho niêm mạc bị thiếu máu cục bộ thúc đẩy nhanh quá trình lành niêm